• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Singular Genomics Systems Inc (NQ: OMIC )

    7.090 +0.440 (+6.62%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Aug 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,768
    Open 6.500
    Bid (Size) 6.700 (1)
    Ask (Size) 7.680 (1)
    Prev. Close 6.650
    Today's Range 6.500 - 7.100
    52wk Range 5.770 - 19.80
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q2 2024
    OMIC stock results show that Singular Genomics Sys beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Singular Genomics Reports Recent Highlights and Second Quarter 2024 Financial Results
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -51.27%
    -51.27%
    1 Month
    -8.87%
    -8.87%
    3 Month
    -36.47%
    -36.47%
    6 Month
    -59.73%
    -59.73%
    1 Year
    -49.72%
    -49.72%

    More News

    Read More
    Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    Singular Genomics Sys: Q4 Earnings Insights
    Via Benzinga
    Preview: Singular Genomics Sys's Earnings
    Via Benzinga
    OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Misses Revenue for Q2 2023
    Via InvestorPlace
    Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday
    Via Benzinga
    Singular Genomics Announces 1-for-30 Reverse Stock Split
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    Recap: Singular Genomics Sys Q3 Earnings
    Via Benzinga
    OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    Singular Genomics to Report First Quarter 2024 Financial Results on May 14, 2024
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    OMIC Stock Earnings: Singular Genomics Sys Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 18, 2024
    Via Benzinga
    Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
    From Singular Genomics Systems, Inc.
    Via GlobeNewswire
    Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.